Document Detail


Alopecia: the case for medical necessity.
MedLine Citation:
PMID:  21548511     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Although alopecia is one of the most prevalent dermatologic conditions in the United States, it is typically viewed as a benign process with only cosmetic consequences. Androgenic alopecia has an especially strong perception as a cosmetic management issue. This contribution reviews literature gathered through MEDLINE from PubMed to emphasize the value of hair as a part of the system and to illustrate that androgenic alopecia, like psoriasis, can have severe consequences and serve as a risk factor for the development of life-threatening diseases. Individuals with alopecia experience psychosocial and psychiatric illness and may be at risk for cardiovascular disease, prostatic cancer, and squamous cell carcinoma of the scalp. All persons with alopecia should be evaluated and treated by a physician to minimize its psychological effects and reduce the risk of developing other medical conditions and be further assessed for the presence of commonly associated comorbid conditions.
Authors:
Kehinde O Ogunmakin; Rashid M Rashid
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Skinmed     Volume:  9     ISSN:  1540-9740     ISO Abbreviation:  Skinmed     Publication Date:    2011 Mar-Apr
Date Detail:
Created Date:  2011-05-09     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101168327     Medline TA:  Skinmed     Country:  United States    
Other Details:
Languages:  eng     Pagination:  79-84     Citation Subset:  IM    
Affiliation:
Department of Dermatology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Improving the quality of quality improvement projects.
Next Document:  Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment ...